Regeneron Falls after Paring Eylea Sales Outlook

... for up to $1.8 billion in revenue. Regeneron stock fell $23.84, or 6 percent, to $271.42 in afternoon trading. The Tarrytown, New York, company said its total revenue from Eylea climbed 48 percent to $722 million. The drug is used to treat "wet" ...

http://ift.tt/1x25aOs